C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 14/81 (2006.01) A61K 38/10 (2006.01) A61K 38/49 (2006.01) A61K 38/55 (2006.01) A61K 51/08 (2006.01) A61L 33/00 (2006.01) C07K 7/02 (2006.01) C07K 7/08 (2006.01) C07K 14/815 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2065150
This invention relates to novel biologically active molecules which bind to and inhibit thrombin. Specifically, these molecules are characterized by a thrombin anion-binding exosite association moiety (ABEAM); a linker portion of at least 18.ANG. in length; and a thrombin catalytic site-directed moiety (CSDM). This invention also relates to compositions, combinations and methods which employ these molecules for therapeutic, prophylactic and diagnostic purposes.
Cette invention concerne de nouvelles molécules biologiquement actives qui se lient à la thrombine et l'inhibent. Plus particulièrement, ces molécules se caractérisent par une fraction d'associations anion de thrombine-exosite de liaison (ABEAM); une portion de liaison d'au moins 18Å de longueur; et une fraction orientée sur le site catalytique de la thrombine (CSDM). Cette invention concerne également des compositions, des combinaisons et des procédés qui utilisent ces molécules à des fins thérapeutiques, prophylactiques et diagnostiques.
Fenton John W. II
Kline Toni
Maraganore John M.
Biogen Inc.
Health Research Incorporated
Sim & Mcburney
LandOfFree
Inhibitors of thrombin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibitors of thrombin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of thrombin will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1398084